Intrinsic Imaging


WCG is a global leader in accelerating clinical research, providing solutions that improve the quality and efficiency of clinical trials while ensuring the highest standards of human subject protection. With over 55 years of experience, WCG connects sponsors, CROs, sites, and participants to deliver safe, impactful, and swift medical therapies.

Industries

biotechnology
clinical-trials
health-care
medical
medical-device
pharmaceutical

Nr. of Employees

medium (51-250)

Intrinsic Imaging


Products

Integrated clinical operations portal

Cloud-based portal for study stakeholders to manage IRB submissions, document workflows, and study communication in a single interface.

Electronic clinical outcome assessment platform

Platform for capture and management of clinical outcome assessments and patient-reported outcomes across visits and devices.

eResearch enterprise CTMS

Clinical trial management system for study build, site tracking, and operational oversight.

Clinical trial listing service

Public-facing registry and listing service to publish clinical trial opportunities and improve patient access.

Medical Imaging Core Lab Services

Comprehensive medical imaging core lab services providing support for Phase I-IV clinical trials and Class I, II, III medical device trials.

Musculoskeletal Clinical Trial Imaging Services

Full-service medical imaging core lab providing specialized imaging services, board-certified musculoskeletal radiologists, and quantitative analysis for musculoskeletal clinical trials.

View All Products

Services

Independent IRB review and determinations for clinical trial protocols, consent documents, and ongoing oversight.

Administration of institutional biosafety committees, biosafety reviews, and support for gene transfer trial oversight.

Design and operational management of blinded endpoint adjudication committees and independent data monitoring committees.

Multichannel recruitment campaigns, on-site enrollment support, prescreening, and retention programs to accelerate enrollment.

Regulatory-compliant adverse event processing, safety reporting and global pharmacovigilance operations for clinical and post-marketing phases.

Genetics-focused protocol design, patient identification by genotype/phenotype, genetic counseling and test interpretation to support trials with genetic components.

View All Services

Expertise Areas

  • IRB and IBC oversight
  • Clinical trial start-up and site activation
  • Participant recruitment and retention
  • Endpoint adjudication and safety monitoring
  • Show More (6)

Key Technologies

  • Electronic clinical outcome assessment (eCOA/ePRO)
  • Clinical trial management systems (CTMS)
  • Electronic trial master file (eTMF) and document integration
  • Cloud-based data analytics and benchmarking databases
  • Show More (4)

News & Updates

WCG Celebrates IBC Review Milestone

WCG's IBC Services has administered over 4,000 convened IBC meetings globally, supporting the safe development of gene transfer therapies.

WCG Opens Office in Japan

WCG expands its global presence with a new office in Tokyo to support complex, international clinical trials.

WCG Acquires Vigilare International

WCG expands its portfolio with Vigilare, a top pharmacovigilance and drug safety solutions provider.

WCG Partners with Inspire for Patient Engagement

WCG partners with Inspire, a large online patient community, to improve patient recruitment and engagement in clinical trials.

WCG Acquires KMR Group and MCC

WCG strengthens its market insights with acquisitions of KMR Group and Metrics Champion Consortium, leaders in benchmarking and analytics.

WCG's Study Accelerator Reduces Timelines by 20%

WCG’s Study Accelerator streamlines review, site selection, and recruitment, leveraging data and real-time insights.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.